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This study assessed the impact of collaborative working with a headache neurologist on 
diagnoses of patients attending orofacial pain (OFP) clinic. Patient diagnostic data was 
collected from adult patients attending an Orofacial Pain Service from January 2013 to 
January 2017. A liaison headache neurologist was appointed late 2015; OFP clinics were co-
run with the neurologist specialist thereafter. Overall, 639 patients attended the service; 315 
in 2013-2015 and 324 in 2016-2017. Compared to 2013-2015, there were increased rates of 
diagnoses related to neurovascular (27.5% vs. 19.0%; P= .012) and musculoskeletal pain 
(36.9% vs. 26.0%; P=.003) in the 2016-2017 cohort and decreased rates of neuropathic 
(55.6% vs 70.2%; P<.001) and atypical/idiopathic pain (1.3% vs. 5.4%; P=.003) diagnoses. 
There was a trend towards an increased rate of comorbid diagnoses (26.3% vs. 20.3%; 
P=.077), especially those relating to headache conditions.  The findings suggest that 
introduction of a specialist headache neurologist into the OFP clinic widened its remit of 
assessment, increasing recognition of (co-morbid) neurovascular-related pain and decreasing 
atypical / idiopathic pain diagnoses in patients with complex OFP. The increase rate of 
musculoskeletal pain diagnosis in the later cohort is likely attributable to service expansion 
and normalisation of diagnostics reportedly seen in other OFP services.    
Statement of Clinical relevance: Orofacial pain is a complex diagnosis, it requires a 
multidisciplinary approach that includes neurological input. 
Key words: Orofacial pain, misdiagnosis, post traumatic neuropathic pain, 
temporomandibular disorder, idiopathic facial pain, headache, neurovascular. 





Misdiagnosis of orofacial pain and poor pain management are one of the most common 
causes of patient complaints related to dentistry (GDC forum data 2016) (1). Dentists are 
familiar with odontogenic pain, however, non-odontogenic pain can mimic toothache leading 
to misdiagnosis and inappropriate management (2).  
Orofacial pain OFP classifications are multiple and conflicting, they  include; 
International Classification of Headache Disorders (ICHD-3β)(3)  (which include headache or 
facial pain caused by disorders of the teeth in Chapter 11 and the other non-dental causes of 
OFP are included in Chapter 13) (3), the International Association for the Study of Pain 
(IASP) (4) classification (which has been modified to acknowledge peripheral and centralised 
driven pain), the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)(5) and the 
American Academy of Orofacial pain(6). The lack of a consensus in diagnostic criteria may 
lead to increased misdiagnosis of OFP (7).  
The numerous causes of OFP reflect the complex anatomical boundaries involved and 
give rise to diagnostic and management challenges for OFP conditions, which require clinical 
input from multiple specialities. Multidisciplinary approaches to diagnosis and management 
of OFP has proven to be cost effective strategy for managing OFP and complex headache 
disorders (8). The orofacial pain service at Kings College Hospital, London consults a high 
volume of OFP patients (>1000 per year) including follow-up visits. Initially, the OFP 
service relied entirely on dental specialities with referral to other specialities without direct 
liaison with neurology. By 2013, clinical psychology and liaison psychiatry were introduced 
to OFP service. Due to recognition of multiple medical and pain co-morbidities in patients 
seen on the OFP service in 2015, a liaison headache neurologist was appointed to the 
Multidisciplinary Team (MDT) to improve diagnostic process and management of a range of 
orofacial pain conditions. In addition to assessing patients with (possible) neurovascular 




conditions, the neurologist facilitated staff training in headache clinical presentation through 
observations of the specialist assessing patients, MDT team discussions with neurology input, 
and an increased emphasis on identifying migraine-headache associated symptoms when 
assessing patients presenting with OFP. In this service evaluation study, we evaluated the 
impact on an existing OFP service of working with a specialist headache neurologist on OFP 
diagnosis. 
Methods 
The study sample included consecutive patients, aged 18 years and above, attending the OFP 
Clinic at King’s College London Hospital from January 2013 to January 2017. The service 
from 2013 was run by a multidisciplinary pain team including; oral surgery, oral medicine, 
clinical psychology and liaison psychiatry, the only newly introduced member (neurology) 
was in early 2016. A need for neurological input was identified due to the medical 
complexity of multiple OFP diagnostics. This coincided with a newly appointed academic 
lead for neurology with headache interest to the main trust hospital in early 2016. In 2016 the 
service became established with increase referrals (from approximately 1800 to 2500 
appointments per year), from other centres. The primary analyses compared the diagnoses 
given to patients attending the OFP Clinic at King’s College London Hospital before and 
after the appointment of a headache Neurologist.  
Clinical examination and diagnosis 
Clinical examination of the patients was performed by trained clinicians in the OFP. A 
diagnosis or diagnoses (in the case of multiple conditions associated with orofacial pain) 
was/were made according to the International Headache Society Classification (3), the 
Research Diagnostic Criteria for Temporomandibular Disorders (9) and the International 
Association for the Study of pain (10). The clinics were co-run with the neurologist specialist. 




Initial assessment was conducted by the oral surgeon and depending on the outcome - if it 
was indicated that a patient required assessments by a neurologist - then this was asked for. 
Data collection 
For patients referred to the clinic from January 2013- December 2015, patients’ case notes 
were retrospectively analysed. In addition to demographic data, relevant information about 
diagnosis and condition history (duration) was extrapolated from case notes. Data for patients 
referred to the clinic from January 2016 – January 2017 was collected prospectively and 
included demographic, diagnosis and condition history. Patients were recruited in accordance 
with approval by the local Trust Research and Development Committee. Ethical approval for 
the study was provided by the National Research Ethics Service Committee, London Dulwich 
(REC number 15/L0/1108). Informed consent was taken from the individual participants for 
their anonymized data to be used for research purposes. 
Data Analysis 
Descriptive data was presented in the form of mean, standard deviation (SD), absolute 
number and percentage (%). Comparisons of demographic variables between 2013-2015 and 
2016-2017 cohorts were performed using independent group t-tests with bias-corrected and 
accelerated [2000 repetitions] bootstrapping methods employed where continuous 
distributions violated normality assumptions. Differential diagnosis rates, grouped together 
based on broad symptomatic classes (neuropathic, musculoskeletal, neurovascular and 
idiopathic (11)) were compared between cohorts using chi-square tests, with odds ratios (OR) 
and 95% confidence intervals (CIs) calculated. The level of significance was set at P < 0·05. 
All statistical analyses were completed with the SPSS, version 24.  
Results 
Over the study period, 639 consecutive adult patients presenting with orofacial pain attended 
the clinic as a result of referrals from general practice or other specialist dental services; 315 




in the 2013-2015 cohort and 324 in the 2016-2017 cohort. The majority of patients were 
female (464 or 73.0%) with no differences between groups (2013-2015 73.4%; 2016-2017 
72.5%; P = 0.806). The mean age was a little under 50 years (Mean (M) = 48.17, SD = 14.26) 
and the age distribution was highly comparable between cohorts (2013-2015 M = 48.11, SD 
= 14.35; 2016-2017 M = 48.23, SD = 14.19; P = 0.917).  The median duration of pain onset 
was 18.0 months (inter-quartile range (IQR) = 7.0-48.0) with 93.1% of patients reporting pain 
for 3 or more months at clinic appointment. Time since pain onset was similar in both cohorts 
(2013-2015 Median = 16.0, IQR = 7.0-36.0; 2016-2017 Median = 18.0, IQR = 7.0-48.0; P = 
0.577). 
Orofacial pain diagnoses 
Data concerning patient diagnosis was examined for all cohort patients. Where patients in the 
2016-2017 cohort had a provisional diagnosis only (17 or 5.2%), this was used. At the time of 
data collection, 4 (1.2%) patients in the 2016-2017 cohort had received neither a formal 
diagnosis nor a provisional diagnosis due to ongoing investigations – these patients were 
excluded from subsequent descriptive and comparative analyses. Almost 30% of 2016-2017 
patients (92 of 320) with a diagnosis had been referred to specialist headache neurologists for 
examination after consultation with oral surgery staff members. 
In total, 148 (23.3%) patients presented with multiple diagnoses. A fifth of (64 or 20.3%) 
patients in the 2013-2015 cohort had multiple diagnoses (2 diagnoses n = 55, 3 diagnoses n = 
9). This increased to more than a quarter (84 or 26.3%) in the 2016 cohort (2 diagnoses n = 
69, 3 diagnoses n = 13, 4 diagnoses n = 2), a difference that was marginally significant (χ2 = 
3.13, P = 0.077).  
___________________ 
Insert Table I about here 




         __________________ 
The frequencies (percentages) of diagnoses associated with patients’ presenting 
orofacial pain for each cohort is displayed in Table 1. With respect to neuropathic pain 
conditions, there were decreases in the proportion of patients with painful post traumatic 
neuropathy (PPTN) and patients with spontaneous neuropathy. The most obvious change, 
however, was the emergence of the diagnosis of persistent dento-alveolar pain 2 (PDAP2) 
under PPTN. This was a reconciliation of problematic recommendations in classification 
guidance for PDAP where it emerged that persistent dento-alveolar pain 1 (PDAP1), 
considered under spontaneous neuropathy, was infrequently diagnosed in both cohorts; 
however PDAP 2 was considered synonymous with PPTN. The proportion of patients 
diagnosed with burning mouth syndrome (BMS) increased very slightly in the 2016-2017 
cohort while a small number of cases of occipital neuralgia and geniculate neuralgia, absent 
in 2013-2015, were identified in the recent cohort.  
The vast majority of TMD diagnoses were myofascial pain of the masticatory muscles 
or joint disc displacement (with or without reduction) and were observed more frequently in 
the 2016-2017 cohort of patients. Within neurovascular pain classifications, trigeminal 
autonomic cephalalgia (TAC) was diagnosed in a small number of cases only, although 10 
patients did receive a diagnosis of hemicrania continua in the 2016-2017 cohort compared 
with none in the earlier cohort. However, the proportion of patients with head migraines (V1) 
and other primary or secondary headaches increased markedly from 2013-2015 to 2016-2017. 
A small number of patients were diagnosed with atypical facial pain / persistent idiopathic 
facial pain (PIFP); 4 patients in the early cohort were diagnosed with atypical odontalgia, a 
sub type of PIFP(3), but none received this diagnosis in 2016-2017 cohort. 
___________________ 




Insert Table II about here 
         __________________ 
Formal comparisons between cohorts of differential diagnosis rates, grouped together 
broadly according to main symptomatic class, revealed several significant differences (Table 
2). Diagnoses of neuropathic pain were less common in 2016-2017, decreasing from over 
70% in 2013-2015 to under 60%. In contrast, the odds of diagnoses of TMD and of 
neurovascular-related conditions both increased by approximately 1.6 fold in the recent 
cohort. More specifically, the proportion of TAC and migraine diagnoses in the 2016-2017 
cohort increased, although differences between cohorts were not significant (Table 2). When 
head migraines were considered separately (Table 1), there was a significant increase (7.9% 
in 2013-2015 to 13.1% in 2016-2017; P = 0.033), however. Most obviously, the odds of a 
diagnosis relating to other primary/secondary headache significantly increased by 2.5 times. 
Finally, there was a significant and marked decrease in the number of diagnoses associated 
with atypical/idiopathic pain given in 2016-2017 compared with 2013-2015. 
___________________ 
Insert Table III about here 
         __________________ 
Analyses indicated significantly higher rates of diagnoses relating to neurovascular 
pain in the 2016-2017 cohort compared to the 2013-2015 cohort, and a trend in the recent 
cohort towards patients receiving multiple diagnoses more frequently. An examination of the 
patterns of diagnostic rates, considering comorbid diagnoses with different symptomatic 
classification, reflected a marginally significant increase in rates of comorbid neurovascular 
and neuropathic and/or musculoskeletal (TMD) pain diagnoses in the 2016-2017 cohort (P = 




.080) rather than a change in comorbid neuropathic and TMD pain diagnoses, which 
decreased slightly (Table 3). Notably, within the 2016-2017 cohort, patients with a diagnosis 
of neurovascular pain were much more likely to be diagnosed with a comorbid orofacial pain 
condition with a different symptomatic classification (e.g., a comorbid neuropathic and/or 
musculoskeletal pain; 53/88 or 60.2%) than patients with a diagnosis related to neuropathic 
pain (31/178 or 17.4%) or a diagnosis of musculoskeletal (TMD) pain (49/118 or 41.5%).   
Discussion 
This study explored the impact of a headache neurologist in an OFP clinic, on diagnoses and 
treatment. Following the introduction of neurology input, we found an increase in the 
diagnoses of neurovascular/headache disorders, most obviously head migraine and other 
primary/secondary headaches, but also a trend for increased recognition of trigeminal 
autonomic cephalalgias (TACs). Furthermore, there was a tendency towards more comorbid 
(symptom classification) diagnoses, predominantly in cases where one or more headache 
conditions were identified. These changes cannot be explained by introduction of new 
clinical guidance, new diagnostic criteria or additional training (other than training in 
headache clinical presentation) of the core OFP service staff. Commissioning of the OFP 
service did not change, however service expansion was observed during the overall period, 
possibly explaining the increase in diagnoses of TMD and related conditions in the second 
cohort. The marked decrease in idiopathic diagnoses and increased neurovascular diagnoses, 
likely reflect additional neurological input in the second cohort, although direct causality is 
not claimed and differences in the distribution of clinical diagnoses may also relate to natural 
changes in patient presentation over time. We nevertheless suggest that OFP clinics co-run 
with the neurologist specialist, which facilitate joint clinic case discussions with feedback on 
the appropriateness of provisional diagnoses and taking more comprehensive headache 
history as part of routine clinical assessment (including asking questions on migraine-




associated and autonomic symptoms), enable clinicians to more often identify non-dental 
facial pain and reduce idiopathic diagnoses.  
The significant decrease in the number of diagnoses of atypical/idiopathic facial pain 
given in 2016-2017 (compared with 2013-2015) to negligible levels represents a positive 
development. The diagnosis of atypical or persistent idiopathic orofacial pain (PIFP) is made 
after excluding all other possible known causes (12), frequently made after thorough 
investigation by several medical specialities and often result in inadequate treatments before 
PIFP is diagnosed(13) (14). In the past PIFP or atypical facial pains were frequently referred to 
as being psychosomatic in origin (15-17), a label which can be distressing for a patient (18). The 
pathophysiology of PIFP largely remains a mystery; and underlying neuropathic mechanism 
has been suggested although the  aetiology needs further exploration (19).  Although the extent 
to which the decrease in atypical/idiopathic facial pain diagnoses in this study is directly 
attributable to improved recognition of primary headache disorders with facial pain radiation 
and/or the education received by clinicians whilst working with a headache trained 
neurologist is unclear, it likely reflects the benefits of adopting an MDT approach at the 
assessment stage. 
The trend for increased trigeminal autonomic cephalalgias (TACs) diagnoses in the 
later cohort is important. TACs are a group of primary headache disorders characterized by 
unilateral head pain that occurs in association with generally prominent ipsilateral cranial 
autonomic features(20). The pain related to TACs is unilateral, normally centered over the V1 
territory. However, radiation of the pain in V2 and V3 is frequently reported, making the 
differential diagnosis with short-lasting paroxysmal OFP condition potentially challenging 
(21). It is essential to distinguish between these conditions to optimize patient management. 
The decrease in proportion of neuropathic pain diagnoses in the recent cohort and 
increase in proportion of TMD diagnoses is more difficult to explain and is unlikely to be 




explained by additional neurological diagnostic input. This particular department specialises 
in post-traumatic neuropathy and has a higher proportion of these patients compared with 
most orofacial pain clinics. It is likely that due to expansion and development of the MDT 
OFP service more patients with TMD were referred to the service impacting on the 
proportions of the diagnostic range. In addition, TMDs with masseteric and temporalis pain 
can be referred to maxillary and mandibular molar teeth which may also complicate diagnosis 
(22).  
The present study observed an increasing trend of comorbid OFP diagnoses from one 
(chronological-based) cohort to the other.  Considering the high comorbid prevalence of 
headaches, this is also likely to be attributable, at least in part, to greater neurology input in 
the diagnostic pathway of the recent cohort. Although the presence of painful comorbidities 
can add to a confusing scenario, given their potential negative impact on disease progression 
and treatment resistance, the importance of classifying comorbid orofacial pain conditions 
cannot be understated (23) For example, while the findings here are consistent with both 
clinical and population-based studies reporting a high prevalence of primary headaches 
associated with TMD (24, 25), there is evidence that the presence of migraine is an important 
factor in both the duration and intensity of TMD pain (26). As such, greater awareness of 
headache classification criteria content by OFP clinic staff, specifically enabled by direct 
liaison with a trained headache neurologist, can help staff to better identify possible 
comorbidities and ultimately increase chance of treatment success (27). 
Strengths and limitations 
The sample size in this study was large and represented all adult patients presenting 
with orofacial pain to national orofacial pain service within a four-year period. Additionally, 
the two timeframes under investigation are consecutive and yielded similar numbers of 
patients in each cohort that were comparable with regard to age, gender and time since pain 




onset.   There are a number of limitations, however. Firstly, the methods of data collection 
differed between cohorts, with retrospective extraction of data from case notes for the early 
cohort in contrast to the latter cohort where data was collected contemporaneously with 
patients’ consultations, which may introduce some inconsistencies. Secondly, although, as 
noted previously, the patient pathway, dental clinical staff and diagnostic criteria were 
consistent over the study period (other than introduction of neurological input), the clinic did 
expand with additional capacity to see more referrals which most commonly are TMD 
conditions in OFP clinics (28). Thirdly, it is difficult to say that if patients with neurovascular 
disorders in the first cohort (2013-2015) were ever referred directly to neurology, and if so, 
what the outcome was. If they were referred and the information on the outcome of the 
consultation was available, it may have resulted in less differences between the two cohorts. 
This needs investigation in future research. Fourthly, there was a significant proportion of 
diagnosed post traumatic neuropathic pain cases, likely due to the clinic lead having a 
specialist interest in this area. This may not reflect in other clinics involved in the care of 
patients presenting with OFP. Finally, although the number of formal comparison was small 
and almost all analyses yielding significant results did so with associated P values of less 
than 0.001, there was no correction for multiple comparisons, raising the risk of Type I 
errors. 
Clinicians attending patients with orofacial pain conditions should ideally have 
additional training in headache disorders to ensure appropriate diagnoses are made. 
Neurological input on clinic joint case discussion and feedback on the appropriateness of the 
provisional diagnosis allows collegiate learning across specialties. The findings of this study 
suggest that increased input by staff trained in headache neurology on orofacial pain clinics 
is associated with a higher rate of primary headache diagnoses, including comorbid 
diagnoses, and a reduction in the number of diagnoses of exclusion, such as PIFP. 




Introduction of neurological input to an OFP service is likely to educate a team that has not 
undergone explicit OFP postgraduate training. Although this is a precedent set in the US 
training programmes(29), it remains poorly established elsewhere. Indeed, specialist training 
in OFP does not yet exist in the UK (30) or mainly outside the USA. This study suggests a 
need for improved training of the dental workforce providing this OFP service and a need for 
a UK based post graduate training programme in OFP.   
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(n = 320) 
 n (%) n (%) 
Neuropathic   
Painful Post Traumatic Neuropathy 151 (47.9) 98 (30.6) 
Persistent Dento-Alveolar Pain 2 0 (0.0) 29 (9.1) 
Spontaneous Neuropathy 26 (8.3) 20 (6.3) 
Persistent Dento-Alveolar Pain 1 4 (1.3) 2 (0.6) 
Burning mouth syndrome 8 (2.5) 11 (3.4) 
Trigeminal Neuralgia Classical 17 (5.4) 15 (4.7) 
Trigeminal Neuralgia Non-classical 19 (6.0) 6 (1.9) 
Occipital Neuralgia 0 (0.0) 8 (2.5) 
Geniculate Neuralgia  0 (0.0) 1 (0.3) 
Musculoskeletal (Temporomandibular Disorders)   
TMJ Myofascial Pain of the Masticatory muscles 52 (16.5) 66 (20.6) 
TMJ Arthritis/Arthalgia 3 (1.0) 3 (0.9) 
TMJ Disc Displacement with/without reduction 26 (8.3) 45 (14.1) 
TMJ Mixed (Muscular and Joint diseases) 1 (0.3) 4 (1.3) 
Neurovascular (Headache disorders)   
Trigeminal Autonomic Cephalalgia   
Unspecified 3 (1.0) 2 (0.6) 
Cluster Headaches 0 (0.0) 1 (0.3) 
SUNCT 3 (1.0) 4 (1.3) 
SUNA 1 (0.3) 0 (0.0) 
Paroxysmal Hemicrania 2 (0.6) 2 (0.6) 
Hemicrania Continua 0 (0.0)  9 (2.8) 
Migraine   
Head Migraine 25 (7.9) 42 (13.1) 
Facial Migraine 12 (3.8) 7 (2.2) 
Other Primary/Secondary Headaches 17 (5.4) 40 (12.5) 
Atypical/Idiopathic   
Persistent Idiopathic Facial Pain 13 (4.1) 5 (1.6) 
Atypical Odontalgia 4 (1.3) 0 (0.0) 
Neurological   
Facial Dystonia 1 (0.3) 0 (0.0) 
Notes: Diagnoses are not mutually exclusive across patients (64 and 84 patients had received more than one 
diagnosis in the 2013-2015 and 2016 cohorts, respectively) - as such, percentages in each column do not add up to 
100%; TMJ = Temporomandibular Joint and Muscle Disorders; SUNCT = Short-Lasting Unilateral Neuralgiform 
Headache Attacks with Conjunctival Injection and Tearing; SUNA = Short-Lasting Unilateral Neuralgiform 





Table II.  Comparison of diagnostic classifications for patients in 2013-2015 and 2016-2017 cohorts according to broad 







(n = 320) 
   
 n (%) n (%) χ2 OR (95% CI) P 
Symptomatic Class      
Neuropathic 221 (70.2) 178 (55.6) 14.36 0.53 (0.38,0.74) <0.001 
Musculoskeletal (Temporomandibular Disorders)   82 (26.0) 118 (36.9) 8.65 1.66 (1.18,2.33) 0.003 
Neurovascular (Headache Disorders)   60 (19.0)  88 (27.5) 6.35 1.61 (1.11,2.34) 0.012 
Trigeminal Autonomic Cephalalgia  9 (2.9) 18 (5.6) 2.99 2.03 (0.90,4.58) 0.084 
Migraine  37 (11.7)  46 (14.4) 0.97 1.26 (0.79,2.01) 0.326 
Other Primary/Secondary headaches 17 (5.4)  40 (12.5) 9.80 2.50 (1.39,4.52) 0.002 
Atypical/Idiopathic Pain 17 (5.4)  4 (1.3) 8.54 0.22 (0.07,0.67) 0.003 
Notes: Classifications under symptomatic class headings are not mutually exclusive across patients (64 and 84 patients had received more than one diagnosis in the 
2013-2015 and 2016 cohorts, respectively) - as such, percentages in each column do not add up to 100%; Chi-square tests were administered for comparisons; OR = 




Table III.  Patterns of diagnostic classifications for patients presenting 
with orofacial pain in 2013-2015 and 2016-2017 cohorts according to 




(n = 303) 
 
2016-2017 
(n = 315) 
Diagnostic Classification n (%) n (%) 
Neuropathic Only 187 (61.7) 147 (46.7) 
Musculoskeletal (TMD) Only 37 (12.2) 69 (21.9) 
Neurovascular Only 24 (7.9) 35 (11.1) 
Neuropathic + Musculoskeletal (TMD) 19 (6.3) 11 (3.5) 
Neuropathic + Neurovascular 10 (3.3) 15 (4.8) 
Musculoskeletal (TMD) + Neurovascular 21 (6.9) 33 (10.5) 
Neuropathic + TMD + Neurovascular 5 (1.7) 5 (1.6) 
Notes: Diagnoses under the ‘Atypical/Idiopathic’ classification were not considered; patients 
with a sole diagnosis under the ‘Atypical/Idiopathic’ classification (e.g., persistent idiopathic 
facial pain) were excluded from the table and comparative analysis (2013-2015 n = 12; 2016 n 
= 5); A 2 (Group) x 7 (Diagnostic Classification) chi-squared test revealed a significant 
difference in proportions in each classification according to cohort (χ2 = 22.08, P = 0.001); 
TMD = temporomandibular joint disorder. 
 
 
 
